Bausch Health
BHC
#4798
Rank
โ‚น195.46 B
Marketcap
โ‚น523.37
Share price
0.37%
Change (1 day)
36.51%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

Revenue for Bausch Health (BHC)

Revenue in 2026 (TTM): โ‚น941.98 Billion

According to Bausch Health 's latest financial reports the company's current revenue (TTM ) is โ‚น1.007 Trillion. In 2025 the company made a revenue of โ‚น921.57 Billion an increase over the revenue in the year 2024 that were of โ‚น825.69 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Bausch Health from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น941.98 B2.22%
2025 โ‚น921.57 B11.61%
2024 โ‚น825.69 B
2022 โ‚น672.26 B7.09%
2021 โ‚น627.75 B6.93%
2020 โ‚น587.04 B-4.29%
2019 โ‚น613.34 B4.68%
2018 โ‚น585.95 B5.19%
2017 โ‚น557.03 B-15.26%
2016 โ‚น657.36 B-5.12%
2015 โ‚น692.83 B32.29%
2014 โ‚น523.72 B46.93%
2013 โ‚น356.44 B83.56%
2012 โ‚น194.18 B49.01%
2011 โ‚น130.31 B146.2%
2010 โ‚น52.93 B39.04%
2009 โ‚น38.06 B4.6%
2008 โ‚น36.39 B10.03%
2007 โ‚น33.07 B-29.66%
2006 โ‚น47.02 B11.56%
2005 โ‚น42.15 B10.05%
2004 โ‚น38.30 B2.13%
2003 โ‚น37.50 B-0.75%
2002 โ‚น37.78 B34.27%
2001 โ‚น28.14 B92.11%
2000 โ‚น14.64 B93.54%
1999 โ‚น7.56 B57.68%
1998 โ‚น4.80 B48.24%
1997 โ‚น3.23 B36.04%
1996 โ‚น2.38 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
OPKO Health
OPK
โ‚น61.43 B-93.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
โ‚น21.62 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA